150 related articles for article (PubMed ID: 26691441)
1. CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells.
Katsuta E; Tanaka S; Mogushi K; Shimada S; Akiyama Y; Aihara A; Matsumura S; Mitsunori Y; Ban D; Ochiai T; Kudo A; Fukamachi H; Tanaka H; Nakayama K; Arii S; Tanabe M
Int J Oncol; 2016 Feb; 48(2):657-69. PubMed ID: 26691441
[TBL] [Abstract][Full Text] [Related]
2. CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.
Cao L; Bridle KR; Shrestha R; Prithviraj P; Crawford DHG; Jayachandran A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163489
[TBL] [Abstract][Full Text] [Related]
3. Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.
Song L; Ye W; Cui Y; Lu J; Zhang Y; Ding N; Hu W; Pei H; Yue Z; Zhou G
Oncotarget; 2017 May; 8(19):31977-31992. PubMed ID: 28404888
[TBL] [Abstract][Full Text] [Related]
4. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
[TBL] [Abstract][Full Text] [Related]
5. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
[TBL] [Abstract][Full Text] [Related]
6. CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.
Lupia M; Angiolini F; Bertalot G; Freddi S; Sachsenmeier KF; Chisci E; Kutryb-Zajac B; Confalonieri S; Smolenski RT; Giovannoni R; Colombo N; Bianchi F; Cavallaro U
Stem Cell Reports; 2018 Apr; 10(4):1412-1425. PubMed ID: 29551673
[TBL] [Abstract][Full Text] [Related]
7. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of the role of extracellular -5'- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition.
Yu J; Liao X; Li L; Lv L; Zhi X; Yu J; Zhou P
In Vitro Cell Dev Biol Anim; 2017 Feb; 53(2):132-140. PubMed ID: 27670764
[TBL] [Abstract][Full Text] [Related]
9. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma.
Ma XL; Hu B; Tang WG; Xie SH; Ren N; Guo L; Lu RQ
J Hematol Oncol; 2020 Feb; 13(1):11. PubMed ID: 32024555
[TBL] [Abstract][Full Text] [Related]
10. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.
Gaur P; Sceusi EL; Samuel S; Xia L; Fan F; Zhou Y; Lu J; Tozzi F; Lopez-Berestein G; Vivas-Mejia P; Rashid A; Fleming JB; Abdalla EK; Curley SA; Vauthey JN; Sood AK; Yao JC; Ellis LM
Gastroenterology; 2011 Nov; 141(5):1728-37. PubMed ID: 21806944
[TBL] [Abstract][Full Text] [Related]
11. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D
BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915
[TBL] [Abstract][Full Text] [Related]
12. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State.
Nguyen AM; Zhou J; Sicairos B; Sonney S; Du Y
Mol Cell Proteomics; 2020 Feb; 19(2):375-389. PubMed ID: 31879272
[TBL] [Abstract][Full Text] [Related]
14. Isolation of cancer progenitor cells from cancer stem cells in gastric cancer.
Shang Z; Xu Y; Liang W; Liang K; Hu X; Wang L; Zou Z; Ma Y
Mol Med Rep; 2017 Jun; 15(6):3637-3643. PubMed ID: 28393208
[TBL] [Abstract][Full Text] [Related]
15. A three-dimensional microenvironment alters CD73 expression in cervical cancer.
Iser IC; de Andrade Mello P; Davies S; de Souza Santos JF; Pilger DA; Buffon A; Bertoni APS; Wink MR
Cell Biochem Funct; 2021 Aug; 39(6):780-790. PubMed ID: 34031899
[TBL] [Abstract][Full Text] [Related]
16. The expression of the MSC-marker CD73 and of NF2/Merlin are correlated in meningiomas.
Kirches E; Steffen T; Waldt N; Hebert E; Pachow D; Wilisch-Neumann A; Keilhoff G; Schneider T; Braunsdorf WEK; Warnke JP; Mawrin C
J Neurooncol; 2018 Jun; 138(2):251-259. PubMed ID: 29468444
[TBL] [Abstract][Full Text] [Related]
17. CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
Petruk N; Tuominen S; Åkerfelt M; Mattsson J; Sandholm J; Nees M; Yegutkin GG; Jukkola A; Tuomela J; Selander KS
Sci Rep; 2021 Mar; 11(1):6035. PubMed ID: 33727591
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance.
Jain D; Somasundaram DB; Aravindan S; Yu Z; Baker A; Esmaeili A; Aravindan N
Cell Biol Toxicol; 2023 Jun; 39(3):967-989. PubMed ID: 34773529
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers.
Jiang T; Xu X; Qiao M; Li X; Zhao C; Zhou F; Gao G; Wu F; Chen X; Su C; Ren S; Zhai C; Zhou C
BMC Cancer; 2018 Mar; 18(1):267. PubMed ID: 29514610
[TBL] [Abstract][Full Text] [Related]
20. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Goswami S; Walle T; Cornish AE; Basu S; Anandhan S; Fernandez I; Vence L; Blando J; Zhao H; Yadav SS; Ott M; Kong LY; Heimberger AB; de Groot J; Sepesi B; Overman M; Kopetz S; Allison JP; Pe'er D; Sharma P
Nat Med; 2020 Jan; 26(1):39-46. PubMed ID: 31873309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]